Virum, Denmark

James Norton McGuire

USPTO Granted Patents = 3 

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2010-2011

Loading Chart...
3 patents (USPTO):Explore Patents

Title: James Norton McGuire: Innovator in Alzheimer's Disease Biomarkers

Introduction

James Norton McGuire is a notable inventor based in Virum, Denmark. He has made significant contributions to the field of Alzheimer's disease research through his innovative work on protein-based biomarkers. With a total of 3 patents, McGuire's inventions aim to improve the diagnosis and treatment of this debilitating condition.

Latest Patents

McGuire's latest patents include groundbreaking discoveries related to biomarkers for Alzheimer's disease. One of his inventions, titled "Saposin D and FAM3C are biomarkers for Alzheimer's disease," provides protein-based biomarkers and biomarker combinations that are useful in qualifying Alzheimer's disease status in a patient. These biomarkers are particularly effective in classifying a subject sample as either Alzheimer's disease or non-Alzheimer's disease. The detection of these biomarkers can be achieved through SELDI mass spectrometry. Another patent focuses on similar protein-based biomarkers that help differentiate between Alzheimer's dementia, non-Alzheimer's dementia, and normal conditions. This invention also outlines appropriate treatment interventions and methods for measuring response to treatment. Notably, certain biomarkers may be suitable for use as radio-labeled ligands in non-invasive imaging techniques such as Positron Emission Tomography (PET).

Career Highlights

Throughout his career, McGuire has worked with various companies, including Vermillion, Inc. and Vermillion Corporation. His work has been instrumental in advancing the understanding of Alzheimer's disease and developing innovative diagnostic tools.

Collaborations

McGuire has collaborated with notable professionals in his field, including Huw Alun Davies and Anja Hviid Simonsen. These collaborations have further enriched his research and contributed to the development of effective biomarkers.

Conclusion

James Norton McGuire's contributions to Alzheimer's disease research through his innovative patents highlight his commitment to improving patient outcomes. His work continues to pave the way for advancements in the diagnosis and treatment of this challenging condition.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…